{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:13Z","timestamp":1747207333993,"version":"3.40.5"},"reference-count":77,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2020,3,5]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Primary Systemic Vasculitides (PSV) are a heterogeneous group of diseases. Outcome\nscores are important to evaluate vasculitis patients in a more structured and standard way and these\nhelp physicians to predict patients with poor prognosis or high risk of relapse. Furthermore, we\nneed reliable outcome measures for clinical trials. There are a number of vasculitis outcome scores\navailable in the clinical practice with different strengths and limitations. These are mainly measures\nof disease activity, disease damage, response to treatment and quality of life. Birmingham Vasculitis\nActivity Score (BVAS) and its pediatric version aim to evaluate a wide scope of PSV. On the\nother hand, some outcome studies have focused on a single vasculitis type since the whole group\nincludes different diseases with heterogeneous clinical features.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The aim of this review is to provide an overview on outcome measures currently being used in the\nevaluation of patients with PSV. We mainly focus on immunoglobulin A vasculitis\/Henochsch\u00f6nlein\npurpura, Kawasaki disease, anti-neutrophil cytoplasmic antibody (ANCA)-associated\nvasculitis, polyarteritis nodosa, Takayasu arteritis and Beh\u00e7et\u2019s disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397115666191126093927","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T12:57:46Z","timestamp":1574773066000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Measuring Vasculitis with Numbers: Outcome Scores"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-2363","authenticated-orcid":true,"given":"Ezgi Deniz","family":"Batu","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-7282","authenticated-orcid":true,"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","volume":"360","author":"Gardner-Medwin J.M.","year":"2002","unstructured":"Gardner-Medwin J.M.; Dolezalova P.; Cummins C.; Southwood T.R.; Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002,360(9341),1197-1202","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/rheumatology\/ker454","volume":"51","author":"Watts R.A.","year":"2012","unstructured":"Watts R.A.; Mooney J.; Skinner J.; Scott D.G.; Macgregor A.J.; The contrasting epidemiology of granulomatosis with polyangiitis (Wegener\u2019s) and microscopic polyangiitis. Rheumatology (Oxford) 2012,51(5),926-931","journal-title":"Rheumatology (Oxford)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11926-011-0232-4","volume":"14","author":"Batu E.D.","year":"2012","unstructured":"Batu E.D.; Ozen S.; Pediatric vasculitis. Curr Rheumatol Rep 2012,14(2),121-129","journal-title":"Curr Rheumatol Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2004.11.006","volume":"19","author":"Watts R.A.","year":"2005","unstructured":"Watts R.A.; Lane S.; Scott D.G.; What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005,19(2),191-207","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.berh.2017.11.009","volume":"31","author":"Sag E.","year":"2017","unstructured":"Sag E.; Batu E.D.; Ozen S.; Childhood systemic vasculitis. Best Pract Res Clin Rheumatol 2017,31(4),558-575","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/03009742.2018.1448111","volume":"47","author":"Batu E.D.","year":"2018","unstructured":"Batu E.D.; Sar\u0131 A.; Erden A.; Comparing immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura) in children and adults: a single-centre study from Turkey. Scand J Rheumatol 2018,47(6),481-486","journal-title":"Scand J Rheumatol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/rheumatology\/key285","volume":"58","author":"Garen T.","year":"2019","unstructured":"Garen T.; Lerang K.; Hoffmann-Vold A.M.; Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides. Rheumatology 2019,58(2),313-320","journal-title":"Rheumatology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3389\/fimmu.2018.01892","volume":"9","author":"Ozen S.","year":"2018","unstructured":"Ozen S.; Batu E.D.; Vasculitis pathogenesis: Can we talk about precision medicine? Front Immunol 2018,9,1892","journal-title":"Front Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"Mukhtyar C.","year":"2009","unstructured":"Mukhtyar C.; Lee R.; Brown D.; Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009,68(12),1827-1832","journal-title":"Ann Rheum Dis"},{"key":"ref=10","first-page":"671","volume":"87","author":"Luqmani R.A.","year":"1994","unstructured":"Luqmani R.A.; Bacon P.A.; Moots R.J.; Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994,87(11),671-678","journal-title":"QJM"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/rheumatology\/keq400","volume":"50","author":"Suppiah R.","year":"2011","unstructured":"Suppiah R.; Mukhtyar C.; Flossmann O.; A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 2011,50(5),899-905","journal-title":"Rheumatology (Oxford)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","volume":"47","author":"Bai Y.H.","year":"2018","unstructured":"Bai Y.H.; Li Z.Y.; Chang D.Y.; Chen M.; Kallenberg C.G.; Zhao M.H.; The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: A study of 504 cases in a single Chinese center. Semin Arthritis Rheum 2018,47(4),524-529","journal-title":"Semin Arthritis Rheum"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10067-011-1838-7","volume":"30","author":"Itabashi M.","year":"2011","unstructured":"Itabashi M.; Takei T.; Morito T.; Estimation of BVAS in patients with microscopic polyangiitis in Japan. Clin Rheumatol 2011,30(11),1499-1505","journal-title":"Clin Rheumatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/1756-185X.13144","volume":"20","author":"Yoo J.","year":"2017","unstructured":"Yoo J.; Kim H.J.; Jung S.M.; Song J.J.; Park Y.B.; Lee S.W.; Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis. Int J Rheum Dis 2017,20(10),1593-1605","journal-title":"Int J Rheum Dis"},{"key":"ref=15","first-page":"S162","volume":"30","author":"Demirkaya E.","year":"2012","unstructured":"Demirkaya E.; Ozen S.; Pistorio A.; Paediatric Rheumatology International Trials Organization (PRINTO). Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides. Clin Exp Rheumatol 2012,30(1)(Suppl. 70),S162-S168","journal-title":"Clin Exp Rheumatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","volume":"72","author":"Dolezalova P.","year":"2013","unstructured":"Dolezalova P.; Price-Kuehne F.E.; \u00d6zen S.; Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis 2013,72(10),1628-1633","journal-title":"Ann Rheum Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/rheumatology\/35.10.958","volume":"35","author":"Guillevin L.","year":"1996","unstructured":"Guillevin L.; Lhote F.; Amouroux J.; Gherardi R.; Callard P.; Casassus P.; Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996,35(10),958-964","journal-title":"Br J Rheumatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"Guillevin L.","year":"2011","unstructured":"Guillevin L.; Pagnoux C.; Seror R.; Mahr A.; Mouthon L.; Le Toumelin P.; French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011,90(1),19-27","journal-title":"Medicine (Baltimore)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"Exley A.R.","year":"1997","unstructured":"Exley A.R.; Bacon P.A.; Luqmani R.A.; Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997,40(2),371-380","journal-title":"Arthritis Rheum"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/03009740802668554","volume":"38","author":"Mohammad A.J.","year":"2009","unstructured":"Mohammad A.J.; Bakoush O.; Sturfelt G.; Segelmark M.; The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI). Scand J Rheumatol 2009,38(4),268-275","journal-title":"Scand J Rheumatol"},{"journal-title":"Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort Clin Exp Rheumatol 2017; 35 Suppl 103(1): 77-82","author":"Omma A","key":"ref=21","unstructured":"Omma A; Erer B; Karadag O;  Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort Clin Exp Rheumatol 2017; 35 Suppl 103(1): 77-82"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1002\/art.21117","volume":"52","author":"Seo P.","year":"2005","unstructured":"Seo P.; Min Y.I.; Holbrook J.T.; WGET Research Group.Damage caused by Wegener\u2019s granulomatosis and its treatment: prospective data from the Wegener\u2019s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005,52(7),2168-2178","journal-title":"Arthritis Rheum"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/annrheumdis-2014-eular.5893","volume":"73","author":"Dolezalova P.","year":"2014","unstructured":"Dolezalova P.; Wilkinson N.; Brogan P.A.; SAT0286 paediatric vasculitis damage index: A new tool for standardised disease assessment. Ann Rheum Dis 2014,73(Suppl. 2),696-697","journal-title":"Ann Rheum Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13075-015-0545-1","volume":"17","author":"Eleftheriou D.","year":"2015","unstructured":"Eleftheriou D.; Varnier G.; Dolezalova P.; McMahon A.M.; Al-Obaidi M.; Brogan P.A.; Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther 2015,17,36","journal-title":"Arthritis Res Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/art.40112","volume":"69","author":"Morishita K.A.","year":"2017","unstructured":"Morishita K.A.; Moorthy L.N.; Lubieniecka J.M.; ARChiVe investigators network within the PedVas Initiative. Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 2017,69(7),1470-1479","journal-title":"Arthritis Rheumatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/ard.60.4.385","volume":"60","author":"Lamprecht P.","year":"2001","unstructured":"Lamprecht P.; Moosig F.; Gause A.; Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2001,60(4),385-390","journal-title":"Ann Rheum Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11926-004-0069-1","volume":"6","author":"Schmidt W.A.","year":"2004","unstructured":"Schmidt W.A.; Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep 2004,6(3),203-211","journal-title":"Curr Rheumatol Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"Schmitt W.H.","year":"2004","unstructured":"Schmitt W.H.; Hagen E.C.; Neumann I.; Nowack R.; Flores-Su\u00e1rez L.F.; van der Woude F.J.;  European Vasculitis Study Group. Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004,65(4),1440-1448","journal-title":"Kidney Int"},{"key":"ref=29","first-page":"31","volume":"55","author":"de Groot K.","year":"2001","unstructured":"de Groot K.; Gross W.L.; Herlyn K.; Reinhold-Keller E.; Development and validation of a disease extent index for Wegener\u2019s granulomatosis. Clin Nephrol 2001,55(1),31-38","journal-title":"Clin Nephrol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"Cella D.","year":"2007","unstructured":"Cella D.; Yount S.; Rothrock N.;  PROMIS Cooperative Group.The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007,45(5)(Suppl. 1),S3-S11","journal-title":"Med Care"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3899\/jrheum.161139","volume":"44","author":"Robson J.C.","year":"2017","unstructured":"Robson J.C.; Tomasson G.; Milman N.; OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 2017,44(10),1529-1535","journal-title":"J Rheumatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2017-212713","volume":"77","author":"Robson J.C.","year":"2018","unstructured":"Robson J.C.; Dawson J.; Doll H.; Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis 2018,77(8),1157-1164","journal-title":"Ann Rheum Dis"},{"key":"ref=33","first-page":"S122","volume":"32","author":"Fidanci B.E.","year":"2014","unstructured":"Fidanci B.E.; Demirkaya E.; Acikel C.; FMF arthritis vasculitis and orphan disease research in paediatric rheumatology. The invisible part of the iceberg: qualitative aspects of childhood vasculitis. Clin Exp Rheumatol 2014,32(3)(Suppl. 82),S122-S127","journal-title":"Clin Exp Rheumatol"},{"key":"ref=34","first-page":"i94","volume":"30","author":"Eleftheriou D.","year":"2015","unstructured":"Eleftheriou D.; Batu E.D.; Ozen S.; Brogan P.A.; Vasculitis in children. Nephrol Dial Transplant 2015,30(Suppl. 1),i94-i103","journal-title":"Nephrol Dial Transplant"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/DAD.0b013e3182157f90","volume":"34","author":"Byun J.W.","year":"2012","unstructured":"Byun J.W.; Song H.J.; Kim L.; Shin J.H.; Choi G.S.; Predictive factors of relapse in adult with Henoch-Sch\u00f6nlein purpura. Am J Dermatopathol 2012,34(2),139-144","journal-title":"Am J Dermatopathol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.rhu.0000255692.46165.19","volume":"13","author":"Prais D.","year":"2007","unstructured":"Prais D.; Amir J.; Nussinovitch M.; Recurrent Henoch-Sch\u00f6nlein purpura in children. J Clin Rheumatol 2007,13(1),25-28","journal-title":"J Clin Rheumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00296-004-0452-2","volume":"25","author":"Rigante D.","year":"2005","unstructured":"Rigante D.; Candelli M.; Federico G.; Bartolozzi F.; Porri M.G.; Stabile A.; Predictive factors of renal involvement or relapsing disease in children with Henoch-Sch\u00f6nlein purpura. Rheumatol Int 2005,25(1),45-48","journal-title":"Rheumatol Int"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/03009740510026841","volume":"35","author":"Shin J.I.","year":"2006","unstructured":"Shin J.I.; Park J.M.; Shin Y.H.; Hwang D.H.; Kim J.H.; Lee J.S.; Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Sch\u00f6nlein purpura. Scand J Rheumatol 2006,35(1),56-60","journal-title":"Scand J Rheumatol"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004217","volume":"95","author":"Calvo-R\u00edo V.","year":"2016","unstructured":"Calvo-R\u00edo V.; Hern\u00e1ndez J.L.; Ortiz-Sanju\u00e1n F.; Relapses in patients with Henoch-Sch\u00f6nlein purpura: Analysis of 417 patients from a single center. Medicine (Baltimore) 2016,95(28)","journal-title":"Medicine (Baltimore)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MOP.0b013e3282f4308b","volume":"20","author":"Sanders J.T.","year":"2008","unstructured":"Sanders J.T.; Wyatt R.J.; IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis. Curr Opin Pediatr 2008,20(2),163-170","journal-title":"Curr Opin Pediatr"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"Egami K.","year":"2006","unstructured":"Egami K.; Muta H.; Ishii M.; Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006,149(2),237-240","journal-title":"J Pediatr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"Kobayashi T.","year":"2006","unstructured":"Kobayashi T.; Inoue Y.; Takeuchi K.; Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006,113(22),2606-2612","journal-title":"Circulation"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"Sano T.","year":"2007","unstructured":"Sano T.; Kurotobi S.; Matsuzaki K.; Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007,166(2),131-137","journal-title":"Eur J Pediatr"},{"journal-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance J Pediatr 2011; 158(5): 831-835: e833","author":"Sleeper LA","key":"ref=44","unstructured":"Sleeper LA; Minich LL; McCrindle BM;  Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance J Pediatr 2011; 158(5): 831-835: e833"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/ped.12755","volume":"58","author":"Kanamitsu K.","year":"2016","unstructured":"Kanamitsu K.; Kakimoto H.; Shimada A.; Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease. Pediatr Int (Roma) 2016,58(2),146-151","journal-title":"Pediatr Int (Roma)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/apa.14249","volume":"107","author":"Kawai R.","year":"2018","unstructured":"Kawai R.; Nomura O.; Tomobe Y.; Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease. Acta Paediatr 2018,107(6),1049-1054","journal-title":"Acta Paediatr"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"Guillevin L.","year":"1996","unstructured":"Guillevin L.; Lhote F.; Gayraud M.; Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996,75(1),17-28","journal-title":"Medicine (Baltimore)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666:AID-ANR116>3.0.CO;2-A","volume":"44","author":"Gayraud M.","year":"2001","unstructured":"Gayraud M.; Guillevin L.; le Toumelin P.; French Vasculitis Study Group. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001,44(3),666-675","journal-title":"Arthritis Rheum"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00296-017-3706-5","volume":"37","author":"Oh Y.J.","year":"2017","unstructured":"Oh Y.J.; Ahn S.S.; Park E.S.; Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa. Rheumatol Int 2017,37(5),685-694","journal-title":"Rheumatol Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/14397595.2017.1337265","volume":"28","author":"Abe Y.","year":"2018","unstructured":"Abe Y.; Tada K.; Yamaji K.; Takasaki Y.; Tamura N.; Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa. Mod Rheumatol 2018,28(2),308-312","journal-title":"Mod Rheumatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/1756-185X.13120","volume":"20","author":"Erden A.","year":"2017","unstructured":"Erden A.; Batu E.D.; S\u00f6nmez H.E.; Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis 2017,20(8),1016-1022","journal-title":"Int J Rheum Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jbspin.2015.01.007","volume":"82","author":"Merlin E.","year":"2015","unstructured":"Merlin E.; Mouy R.; Pereira B.; Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa. Joint Bone Spine 2015,82(4),251-257","journal-title":"Joint Bone Spine"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.38024","volume":"65","author":"Eleftheriou D.","year":"2013","unstructured":"Eleftheriou D.; Dillon M.J.; Tullus K.; Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 2013,65(9),2476-2485","journal-title":"Arthritis Rheum"},{"author":"Oh YJ","key":"ref=54","unstructured":"Oh YJ; Ahn SS; Park ES; Chest and renal involvements,\nBirmingham vascular activity score more than 13.5 and five factor\nscore (1996) more than 1 at diagnosis are significant predictors of\nrelapse of microscopic polyangiitis Clin Exp Rheumatol 2017; 35\nSuppl 103(1): 47-54."},{"key":"ref=55","first-page":"65","volume":"36","author":"Mun C.H.","year":"2018","unstructured":"Mun C.H.; Yoo J.; Jung S.M.; Song J.J.; Park Y.B.; Lee S.W.; The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre. Clin Exp Rheumatol 2018,36(2)(Suppl. 111),65-72","journal-title":"Clin Exp Rheumatol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ard.2008.097758","volume":"68","author":"Merkel P.A.","year":"2009","unstructured":"Merkel P.A.; Cuthbertson D.D.; Hellmich B.;  Vasculitis Clinical Research Consortium.Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Ann Rheum Dis 2009,68(1),103-106","journal-title":"Ann Rheum Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3899\/jrheum.111030","volume":"39","author":"Morishita K.","year":"2012","unstructured":"Morishita K.; Li S.C.; Muscal E.; ARChiVe Investigators Network. Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol 2012,39(5),1088-1094","journal-title":"J Rheumatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912:AID-ANR148>3.0.CO;2-5","volume":"44","author":"Stone J.H.","year":"2001","unstructured":"Stone J.H.; Hoffman G.S.; Merkel P.A.; International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001,44(4),912-920","journal-title":"Arthritis Rheum"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1080\/0886022X.2017.1349675","volume":"39","author":"Kucuk H.","year":"2017","unstructured":"Kucuk H.; Varan O.; Goker B.; Serum ferritin as an activity marker for granulamotosis with polyangiitis. Ren Fail 2017,39(1),566-569","journal-title":"Ren Fail"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"723","DOI":"10.6061\/clinics\/2017(12)02","volume":"72","author":"Perez M.O.","year":"2017","unstructured":"Perez M.O.; Oliveira R.M.; Levy-Neto M.; Caparbo V.F.; Pereira R.M.R.; Serum 25-hydroxyvitamin D levels in patients with Granulomatosis with Polyangiitis: association with respiratory infection. Clinics (S\u00e3o Paulo) 2017,72(12),723-728","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.autrev.2013.11.003","volume":"13","author":"Thai L.H.","year":"2014","unstructured":"Thai L.H.; Charles P.; Resche-Rigon M.; Desseaux K.; Guillevin L.; Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener\u2019s) relapses? Results of a retrospective study on 126 patients. Autoimmun Rev 2014,13(3),313-318","journal-title":"Autoimmun Rev"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/art.38248","volume":"66","author":"Tomasson G.","year":"2014","unstructured":"Tomasson G.; Davis J.C.; Hoffman G.S.; Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Rheumatol 2014,66(2),428-432","journal-title":"Arthritis Rheumatol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"iii6","DOI":"10.1093\/rheumatology\/keh739","volume":"44","author":"Sivakumar M.R.M.R.","year":"2005","unstructured":"Sivakumar M.R.M.R.; Bacon P.A.; The Indian perspective of Takayasu arteritis and development of a disease extent index (DEI.Tak) to assess Takayas\u0131 arteritis. Rheumatology (Oxford) 2005,44,iii6-iii7","journal-title":"Rheumatology (Oxford)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/rheumatology\/ket128","volume":"52","author":"Misra R.","year":"2013","unstructured":"Misra R.; Danda D.; Rajappa S.M.; Indian Rheumatology Vasculitis (IRAVAS) group.Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 2013,52(10),1795-1801","journal-title":"Rheumatology (Oxford)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/1756-185X.12967","volume":"20","author":"John R.A.","year":"2017","unstructured":"John R.A.; Keshava S.N.; Danda D.; Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu\u2019s arteritis. Int J Rheum Dis 2017,20(7),882-886","journal-title":"Int J Rheum Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/ket289","volume":"52","author":"Sinha D.","year":"2013","unstructured":"Sinha D.; Mondal S.; Nag A.; Ghosh A.; Development of a colour Doppler ultrasound scoring system in patients of Takayasu\u2019s arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology (Oxford) 2013,52(12),2196-2202","journal-title":"Rheumatology (Oxford)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jcmg.2012.01.013","volume":"5","author":"Tezuka D.","year":"2012","unstructured":"Tezuka D.; Haraguchi G.; Ishihara T.; Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012,5(4),422-429","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3899\/jrheum.140817","volume":"42","author":"Alibaz-Oner F.","year":"2015","unstructured":"Alibaz-Oner F.; Aydin S.Z.; Akar S.; Assessment of patients with takayasu arteritis in routine practice with indian takayasu clinical activity score. J Rheumatol 2015,42(8),1443-1447","journal-title":"J Rheumatol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.semarthrit.2017.09.014","volume":"47","author":"Goel R.","year":"2018","unstructured":"Goel R.; Danda D.; Joseph G.; Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India. Semin Arthritis Rheum 2018,47(5),718-726","journal-title":"Semin Arthritis Rheum"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13075-017-1452-4","volume":"19","author":"Aeschlimann F.A.","year":"2017","unstructured":"Aeschlimann F.A.; Eng S.W.M.; Sheikh S.; Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther 2017,19(1),255","journal-title":"Arthritis Res Ther"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-017-0164-2","volume":"15","author":"Feng Y.","year":"2017","unstructured":"Feng Y.; Tang X.; Liu M.; Zhou J.; Zhao X.; Li Q.; Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China. Pediatr Rheumatol Online J 2017,15(1),29","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3899\/jrheum.161467","volume":"44","author":"Sreih A.G.","year":"2017","unstructured":"Sreih A.G.; Alibaz-Oner F.; Kermani T.A.; Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016. J Rheumatol 2017,44(12),1933-1937","journal-title":"J Rheumatol"},{"key":"ref=73","volume":"134","author":"Davatchi F.A.M.","unstructured":"Davatchi F.A.M.; Shahram F.; Tebbi M.; Chams C.; Chams H.; Iran Behcet\u2019s disease dynamic activity measure. Abstracts of the XII European congress of rheumatology Hungrian Rheumatol 32 ,134","journal-title":"Abstracts of the XII European congress of rheumatology Hungrian Rheumatol 32"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"Bhakta B.B.","year":"1999","unstructured":"Bhakta B.B.; Brennan P.; James T.E.; Chamberlain M.A.; Noble B.A.; Silman A.J.; Beh\u00e7et\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999,38(8),728-733","journal-title":"Rheumatology (Oxford)"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","volume":"19","author":"Shahram F.","year":"2009","unstructured":"Shahram F.; Khabbazi A.; Nadji A.; Ziaie N.; Banihashemi A.T.; Davatchi F.; Comparison of existing disease activity indices in the follow-up of patients with Beh\u00e7et\u2019s disease. Mod Rheumatol 2009,19(5),536-541","journal-title":"Mod Rheumatol"},{"key":"ref=76","first-page":"119","volume":"35","author":"Batu E.D.","year":"2017","unstructured":"Batu E.D.; Sonmez H.E.; Sozeri B.; The performance of different classification criteria in paediatric Behcet\u2019s disease. Clin Exp Rheumatol 2017,35(6)(Suppl. 108),119-123","journal-title":"Clin Exp Rheumatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3899\/jrheum.161352","volume":"44","author":"Hatemi G.","year":"2017","unstructured":"Hatemi G.; Meara A.; Ozguler Y.; Developing a Core Set of Outcome Measures for Beh\u00e7et Disease: Report from OMERACT 2016. J Rheumatol 2017,44(11),1750-1753","journal-title":"J Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T08:28:15Z","timestamp":1585384095000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176983\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397115666191126093927","relation":{},"ISSN":["1573-3971"],"issn-type":[{"type":"print","value":"1573-3971"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}